GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Arvaya Healthcare Ltd

Arvaya Healthcare completes 100% acquisition of Sushodha Institute of Gastroenterology

M&A ▲ Positive Development LOW RISK
📅 Filed on BSE: 01 Nov 2026, 06:54 PM IST  ·  BSE ID: 2819f588-d8a8-4a22-a842-c1e251dff652
View Original BSE Filing (PDF)
💡
In Simple Terms
The company fully bought Sushodha Institute of Gastroenterology Private Limited, making it a complete subsidiary.
🤖 AI Summary
  • Arvaya Healthcare Limited completed acquisition of 1,84,374 equity shares, constituting 100% of SIGPL.
  • Sushodha Institute of Gastroenterology Private Limited (SIGPL) is now a wholly-owned subsidiary.
  • The acquisition became effective on November 1, 2026, following prior board approval.
  • Board approved the acquisition for Rs. 15,48,74,160/- and a Rs. 210 Crores Rights Issue on July 11, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares Acquired
1,84,374 equity shares
Percentage of Equity Acquired
100%
Acquisition Value
Rs. 15,48,74,160/-
Rights Issue Approved
Rs. 210 Crores
🏢 How This Affects the Company
📈
Business Impact
This acquisition integrates Sushodha Institute of Gastroenterology Private Limited into Arvaya Healthcare, potentially expanding its service offerings in gastroenterology.
💰
Financial Impact
The completed acquisition adds SIGPL's financials to Arvaya Healthcare's consolidated statements from November 1, 2026, reflecting the Rs. 15,48,74,160/- acquisition cost.
⚙️
Operational Impact
SIGPL now operates as a wholly-owned subsidiary, aligning its operations and management structure with Arvaya Healthcare Limited.
👥 What This Means For Shareholders
✅
Action Required
No direct action is required from shareholders based on this acquisition completion intimation.
👤
Who Is Affected
Existing shareholders of Arvaya Healthcare Limited will see SIGPL's financial performance consolidated into the parent company's results from November 1, 2026.
🔍
Management Signal
Management is actively pursuing strategic growth through acquisitions, as evidenced by the completed integration of SIGPL.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 results — monitor consolidated financials including SIGPL's contribution.
Detailed reports on integration of Sushodha Institute of Gastroenterology.
Update on the Rs. 210 Crores Rights Issue process and timelines.
LOW RISK This filing confirms completion of a previously approved strategic acquisition.
💡 Investor Takeaway
Arvaya Healthcare Limited has completed the acquisition of 100% equity share capital of Sushodha Institute of Gastroenterology Private Limited (SIGPL) for Rs. 15,48,74,160/- on November 1, 2026, making it a wholly-owned subsidiary.
⚖️ Strengths & Concerns

✅ Positives

  • Completion of 100% equity acquisition provides full control over Sushodha Institute of Gastroenterology Private Limited's operations.
  • Integration of SIGPL as a wholly-owned subsidiary streamlines strategic alignment and resource allocation.
📅 Company Track Record
On July 11, 2026, Arvaya Healthcare Limited's (formerly Bijoy Hans Limited) Board approved the acquisition of SIGPL for Rs. 15,48,74,160/- and a Rs. 210 Crores Rights Issue. This current filing confirms the successful completion of that acquisition.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What has Arvaya Healthcare Limited acquired?
Arvaya Healthcare Limited has acquired 1,84,374 equity shares, constituting 100% of the equity share capital of Sushodha Institute of Gastroenterology Private Limited (SIGPL).
When did Arvaya Healthcare Limited complete the acquisition?
The acquisition of Sushodha Institute of Gastroenterology Private Limited was successfully completed on November 1, 2026.
What is the status of Sushodha Institute of Gastroenterology Private Limited after this acquisition?
Consequent upon completion of the acquisition, Sushodha Institute of Gastroenterology Private Limited has become a wholly-owned subsidiary of Arvaya Healthcare Limited from November 1, 2026.
What was the approved acquisition value for SIGPL?
The acquisition of SIGPL was approved by the Board for Rs. 15,48,74,160/-, as per the earlier intimation.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.